Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Sharon P. Wilczynski"'
Autor:
Bernard Tegtmeier, Sanjeet Dadwal, James I Ito, Margarita Semis, Sharon P. Wilczynski, Markus Kalkum
Publikováno v:
Clinical Infectious Diseases. 72:1386-1391
Background The toxigenic mold Stachybotrys has controversially been linked to idiopathic pulmonary hemorrhage and “sick building syndrome.” However, there are no previous clinical records of invasive stachybotryosis. Methods Sinus biopsy specimen
Publikováno v:
Gastroenterology. 162:e9-e10
Autor:
Joanne E. Mortimer, Linda Steele, Susan L. Neuhausen, Yuan Yuan, Sharon P. Wilczynski, Charles Warden, Yuan Chun Ding
Publikováno v:
Oncotarget
Molecular subtypes of triple negative breast cancer (TNBC) are associated with variation in survival and may assist in treatment selection. However, the association of patient race or ethnicity with subtypes of TNBC and clinical outcome has not been
Autor:
Theodore C. Goldstein, Parameet Kumar, Santanu Raychaudhuri, Natarajan Venkatesan, Marcus Gallagher-Jones, Marco Morselli, Daniel Sanghoon Shin, Saroj K. Basak, Roopa Biswas, Matteo Pellegrini, Jing Lu, Trent Su, Eri S. Srivatsan, Sharon P. Wilczynski, Mysore S. Veena, Rita Chakrabarti, Haiquing Fu, Matthew Rettig, Mirit I. Aladjem
Publikováno v:
The Journal of biological chemistry, vol 295, iss 50
J Biol Chem
J Biol Chem
We have observed overexpression of PACS-1, a cytosolic sorting protein in primary cervical tumors. Absence of exonic mutations and overexpression at the RNA level suggested a transcriptional and/or posttranscriptional regulation. University of Califo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dd9515db6c5b92672b9eee20278a4f9
https://escholarship.org/uc/item/1h59m8rz
https://escholarship.org/uc/item/1h59m8rz
Autor:
James Shen, Mihaela C. Cristea, Scott Glaser, Christina Hsiao Wei, Daphne Stewart, Siamak Saadat, Edward Wang, Richard Li, Stephen J. Lee, Susan Shehayeb, Ernest S. Han, Thanh H. Dellinger, Sharon P. Wilczynski, Sariah Liu, Lorna Rodriguez-Rodriguez
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 2830, p 2830 (2020)
Journal of Clinical Medicine, Vol 9, Iss 2830, p 2830 (2020)
Epithelial ovarian cancer (EOC) is the most common histology of ovarian cancer defined as epithelial cancer derived from the ovaries, fallopian tubes, or primary peritoneum. It is the fifth most common cause of cancer-related death in women in the Un
Autor:
Xiwei Wu, Lihong Weng, Xuejun Li, Chao Guo, Sumanta K Pal, Jennifer M Jin, Yuping Li, Rebecca A Nelson, Bing Mu, Susan H Onami, Jeffrey J Wu, Nora H Ruel, Sharon P Wilczynski, Hanlin Gao, Maricela Covarrubias, Robert A Figlin, Lawrence M Weiss, Huiqing Wu
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e35661 (2012)
Renal cell carcinoma (RCC) metastasis portends a poor prognosis and cannot be reliably predicted. Early determination of the metastatic potential of RCC may help guide proper treatment. We analyzed microRNA (miRNA) expression in clear cell RCC (ccRCC
Externí odkaz:
https://doaj.org/article/f3227c21da124396adcaf9c1945988d6
Publikováno v:
Journal of Oncology Practice. 14:569-571
Autor:
Amy Hakim, L. Rodriguez, Thanh H. Dellinger, Mihaela C. Cristea, Paul Frankel, M. Tran, Scott Glaser, Lindsay Kilpatrick, Y-J. Chen, Robert J. Morgan, Stephen J. Lee, Ernest S. Han, Mark T. Wakabayashi, Melissa Eng, Alex Jung, Gottfried E. Konecny, Daphne Stewart, Sharon P. Wilczynski, Edward Wang, Timothy W. Synold
Publikováno v:
Annals of Oncology. 31:S639
Autor:
Mysore S. Veena, Daniel Sanghoon Shin, Chan Jeong, Jenna R. Chatoff, Natarajan Venkatesan, Saroj K. Basak, David Gray, Sharon P. Wilczynski, Steven J. Gray, Donald B. Kohn, Marilene B. Wang, Eri S. Srivatsan
Publikováno v:
Cancer Research. 80:5986-5986
Gigaxonin, the protein product of the Giant axonal neuropathy (GAN) gene, is a E3 ubiquitin ligase involved in neural cell and fibroblast intermediate filament processing. We have previously shown that Gigaxonin interacts with p16 in cisplatin-mediat
A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas
Autor:
David R. Gandara, James C. Hu, Sharon P. Wilczynski, Nora Ruel, Paul Frankel, Min Guan, Warren Chow, Zeynep Eroglu, Scott D Christensen, Hussein Tawbi
Publikováno v:
British Journal of Cancer
Background: The MEK inhibitor, selumetinib, suppresses soft-tissue sarcoma (STS) cell proliferation in vitro. Mammalian target of rapamycin inhibitors possess modest activity against STS; however, resistance develops via MAPK pathway feedback activat